These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 8601418)
1. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor. Burgaud JL; Baserga R Exp Cell Res; 1996 Mar; 223(2):412-9. PubMed ID: 8601418 [TBL] [Abstract][Full Text] [Related]
2. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor. Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor treatment switches δ-opioid receptor-stimulated extracellular signal-regulated kinases 1 and 2 signaling from an epidermal growth factor to an insulin-like growth factor-1 receptor-dependent mechanism. Eisinger DA; Ammer H Mol Pharmacol; 2011 Feb; 79(2):326-35. PubMed ID: 21078885 [TBL] [Abstract][Full Text] [Related]
4. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Starbuck C; Lauffenburger DA Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559 [TBL] [Abstract][Full Text] [Related]
6. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA. Li J; Ma C; Huang Y; Luo J; Huang C Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes. Hallak H; Moehren G; Tang J; Kaou M; Addas M; Hoek JB; Rubin R Hepatology; 2002 Dec; 36(6):1509-18. PubMed ID: 12447877 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor. Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852 [TBL] [Abstract][Full Text] [Related]
10. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Rubini M; Hongo A; D'Ambrosio C; Baserga R Exp Cell Res; 1997 Feb; 230(2):284-92. PubMed ID: 9024787 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. DeAngelis T; Ferber A; Baserga R J Cell Physiol; 1995 Jul; 164(1):214-21. PubMed ID: 7790393 [TBL] [Abstract][Full Text] [Related]
13. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Dews M; Nishimoto I; Baserga R Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824 [TBL] [Abstract][Full Text] [Related]
14. The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines. Helin K; Velu T; Martin P; Vass WC; Allevato G; Lowy DR; Beguinot L Oncogene; 1991 May; 6(5):825-32. PubMed ID: 1646987 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211 [TBL] [Abstract][Full Text] [Related]
16. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells. Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637 [TBL] [Abstract][Full Text] [Related]
17. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890 [TBL] [Abstract][Full Text] [Related]
18. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression. Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805 [TBL] [Abstract][Full Text] [Related]
20. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Miura M; Li S; Baserga R Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]